Unraveling Stories Connecting Communities
Image credit: Svetlana | stock.adobe.com Results from the Phase III XTEND-Kids trial (NCT04759131) found that once-weekly Altuviiio (efanesoctocog alfa) produced…
Image Credit: © Blue Planet Studio – stock.adobe.com Rett syndrome, a rare genetic neurological and developmental disorder that primarily affects…
Image Credit: © yodiyim – stock.adobe.com Teva Pharmaceuticals has shared new results from the Phase III SPACE clinical trial (NCT03539393)…
Image credit: JeromeCronenberger | stock.adobe.com Findings from a Phase II/III study show postexposure prophylaxis with Paxlovid (nirmatrelvir–ritonavir; Pfizer) for five…
Image Credit: © Dr_Microbe – stock.adobe.com The Phase III ARANOTE trial (NCT04736199) of Bayer’s NUBEQA (darolutamide) plus androgen deprivation therapy…
Image Credit: © Pixel-Shot – stock.adobe.com Emerging two-year data from a pair of Phase III studies—Pagoda (NCT04108156) and Pavilion (NCT04503551)—evaluating…
Image Credit: © NicoElNino – stock.adobe.com There is no doubting the impact of the COVID-19 pandemic on clinical research. According…
Image credit: magicmine | stock.adobe.com Patients aged 80 years and above with atrial fibrillation (AF) may gain a benefit from…
Tom deLaubenfels, PhD, Director of Data Science, Strados Labs In respiratory clinical trials, cough frequency monitoring can serve as a…
Image credit: vukkostic | stock.adobe.com Data from the Phase III RAISE trial (NCT05295173) show treatment with reteplase has a greater…
Image Credit: © Aerial Mike – stock.adobe.com The FDA has cleared Artelo Biosciences’ Investigational New Drug application (IND) for ART26.12,…
Image credit: Andrew Dorey | stock.adobe.com Findings from the Phase I-II 2022-CM313-ITP trial (NCT05694767) show that an investigational anti-CD38 targeted…
Image Credit: © iDoPixBox – stock.adobe.com IDEAYA Biosciences has shared positive clinical data for the IDE397 Phase II monotherapy expansion…
Image Credit: © peterschreiber.media – stock.adobe.com Prelude Therapeutics has announced a new clinical trial collaboration and supply agreement with Merck…
ACT: How can sponsors embed patient and caregiver insights into product vision and design? Birchard: I’m currently a product owner,…
ACT: What are your initial thoughts on FDA releasing the Diversity Action Plan guidance? Smith: My initial thoughts on the…
Image Credit: © Christoph Burgstedt – stock.adobe.com The FDA has granted Fast Track Designation to Obsidian Therapeutics’ OBX-115, a novel…
Image credit: kh_art | stock.adobe.com Results from the Phase II INTUITT-NF2 trial (NCT04374305) show brigatinib produced radiographic responses across multiple…
Image Credit: © VadimGuzhva – stock.adobe.com Pfizer announced it has selected its preferred once-daily modified release formulation for danuglipron, an…
Image credit: PH alex aviles | stock.adobe.com An observational study (NCT06030505) in a real-world setting found that Beyfortus (nirsevimab) lowers the…
ACT: How can sponsors leverage electronic clinical outcome assessment (eCOA) technologies to facilitate the collection and management of patient-reported outcomes…
Image credit: Crystal light | stock.adobe.com Data from the Phase III innovaTV 301/ENGOT-cx12/GOG-3057 trial (NCT04697628) show second- or third-line treatment…
ACT: What strategies can sponsors employ to bridge the gaps between study participants and the industry, ensuring open and continuous…
Image credit: peterschreiber.media | stock.adobe.com Results from the Phase III NOTUS trial (NCT04456673) demonstrated that Dupixent (dupilumab; Sanofi and Regeneron)…
ACT: Why should sponsors prioritize incorporating patient and caregiver perspectives into clinical trial design and conduct? Birchard: I love this…
Image credit: ZayNyi | stock.adobe.com The results of the Phase III OASIS-HAE (NCT05139810) clinical trial and OASISplus open-label extension (OLE) trial…
June 27th 2024 Article AI can be applied to patient data in real time, allowing medical reviewer teams to actively…
ACT: Looking forward, where do you see the use of artificial intelligence (AI) in clinical trials in five years? Lacroix:…
Image Credit: © Aerial Mike – stock.adobe.com Emerging data released from Sanofi show its CD40L monoclonal antibody, frexalimab, reduced a…
Tenaerts: It was awaited, so we’re all happy it came out and I think it’s going in the right direction.…
Image Credit: © photon_photo – stock.adobe.com The FDA has cleared Vir Biotechnology’s investigational new drug (IND) application and granted Fast…
Image Credit: © Aerial Mike – stock.adobe.com The FDA has cleared GT Biopharma’s Investigational New Drug (IND) application for GTB-3650.…
Tenaerts: I think it’ll help the industry get more data, actionable data on a diverse population—there’s different ways to do…
Nick Slack, Chairman and CEO, START Center for Cancer Research Clinical trials can offer patients who have run out of…
Image Credit: Adobe Stock Images/Hunterframe Boehringer Ingelheim and Gubra have launched a Phase I clinical trial for BI 3034701, a…
Image Credit: © Matthieu – stock.adobe.com Sirnaomics has announced its small interfering RNA (siRNA) drug candidate, STP707, showed a strong…
Image Credit: Adobe Stock Images/fotoyou The National Institutes of Health (NIH) has begun a Phase I clinical trial to test…
Discover how streamlining patient screening can help accelerate clinical trials. Simplifying and improving the patient journey and optimized screening processes…
Image Credit: Adobe Stock Images/Lila Patel Results from the Phase III Vivacity-MG3 trial show that Johnson & Johnson’s (J&J) nipocalimab…
AI can be applied to patient data in real time, allowing medical reviewer teams to actively monitor patient safety, with…
Introducing OpenBioLLM-Llama3-70B & 8B: Saama’s AI Research Lab Released the Most Openly Available Medical-Domain LLMs to Date
Image credit: shidlovski | stock.adobe.com Phase III trial data published by The New England Journal of Medicine (NEJM) show the efficacy…
Image credit: Sebastian Kaulitzki | stock.adobe.com The combination of Rybrevant (amivantamab-vmjw; Janssen Pharmaceutical) with Leclaza (lazertinib; Johnson & Johnson) produced…
Image credit: Deemerwha studio | stock.adobe.com Patient experience data (PED) are no longer a nice to have; it is emerging…
ACT: What should industry stakeholders be keeping top of mind when implementing artificial intelligence (AI) into their workflows? Lacroix: When…
ACT: What are the greatest benefits to utilizing artificial intelligence (AI) in data management? Lacroix: Coming from a data management…
Image Credit: © Andrii Yalanskyi – stock.adobe.com The National Comprehensive Cancer Network (NCCN) has published new results for its latest…
ACT: How can data management challenges be addressed? Specifically, is there any opportunity to address them with artificial intelligence (AI)?…
Image Credit: © Jakub Krechowicz – stock.adobe.com The FDA has issued a draft guidance which provides details to medical product…
ACT: What are some of the biggest challenges you are currently seeing with data management in clinical trials? Lacroix: Since…
Image Credit: © Crystal light – stock.adobe.com Adicet Bio has announced that the FDA has cleared its Investigational New Drug…
Image Credit: © terovesalainen – stock.adobe.com Eli Lilly has announced results from its Phase III clinical trials of tirzepatide for…
Image Credit: © putilov_denis – stock.adobe.com In recent years, there has been a growing interest in the use of patient-reported…
As medical facilities become more equipped to handle different telemedicine platforms and procedures, more clinical trials are back up and…
Although biologics and biosimilar drugs only represent 2% of U.S. prescription volume, these naturally sourced medications have recently become the…
Image Credit: Andy Studna In a session at the 2024 DIA Global Annual meeting in San Diego, CA, Jane Myles,…
Image credit: Matthieu | stock.adobe.com Johnson & Johnson has submitted a supplemental Biologics License Application (sBLA) to the FDA for…
Sandra Smith, RN, MSN, AOCN, Senior Vice President, Clinical Solutions and Strategic Partnerships at WCG. Site activation of new clinical…
ACT: What are currently some of the greatest regulatory challenges industry stakeholders such as CROs and sponsors should be keeping…
Image credit: Corona Borealis | stock.adobe.com The clinical research industry has historically operated with a focus on effectively and efficiently…
ACT: How is FDA promoting innovation in clinical trial design and conduct? Cuff Shimooka: It’s a timely question, having just…
Image Credit: Adobe Stock Images/Sebastian Kaulitzki Results from the Phase III CAPItello-290 trial evaluating AstraZeneca’s Truqap (capivasertib) in combination with…
ACT: What do you think are some of the greatest opportunities for integrating artificial intelligence (AI) into clinical research? DiCicco:…
ACT: What are you looking forward to working on and achieving with FDA under the renewed CRADA agreement? Hughes: We…
Image credit: wladimir1804 | stock.adobe.com Introduction The increasing focus on diversity in clinical trials by regulatory authorities worldwide, combined with…
Image credit: rost9 | stock.adobe.com Findings from the Phase III NextCOVE (NCT05815498) trial of Moderna’s mRNA-1283 showed the next-generation, investigational…
Image Credit: Adobe Stock Images/Oksana Smyshliaeva The FDA has granted accelerated approval to Bristol Myers Squibb’s (BMS) Augtyro (repotrectinib), a…
Image credit: LASZLO | stock.adobe.com Findings from the Phase II MagnetisMM-3 trial (NCT04649359) showed a significant survival benefit with Elrexfio…
ACT: How can we improve shared decision-making practices as ways to improve the quality of care for cancer patients? Buyse:…
Image Credit: © lidiia – stock.adobe.com EQT has announced that the EQT Healthcare Growth Strategy and the EQT Growth Fund…
ACT: How is clinical trial design and analysis changing in response to more comprehensive evaluation methods (methods that consider the…
Image credit: Sweettymojidesign | stock.adobe.com Two-year data from the Phase III BE MOBILE 1, BE MOBILE 2, and the open-label…
ACT: How can we transform cancer care through more patient-centered research and treatment analysis? Buyse: Just building on what Sebastien…
Image credit: Crystal light | stock.adobe.com Two-year interim data from the Phase III ASSURE trial (NCT03301506) show sustained and long-term…
ACT: What are some of the unique challenges facing oncology trials today? Buyse: Well, I think there are many challenges,…
Applied Clinical Trials June 2024 Issue (PDF) Sustainability: More than Meets the Eye Status Check: Science & Sustainability Aligning Patient…
Image Credit: © putilov_denis – stock.adobe.com Systematic reviews are a key element of clinical research. While these reviews must be…
Image Credit: © Murrstock – stock.adobe.com We presented an initial review of quality tolerance limit (QTL) adoption trends in the…
Image credit: Dr_Microbe | stock.adobe.com Elahere (mirvetuximab soravtansine; AbbVie) achieved both the primary and secondary endpoints of the Phase II…
Image Credit: © Supapeach – stock.adobe.com A few points to review before we reach the heart of this how-green-are-they-getting look…
Image Credit: © Катерина Євтехова – stock.adobe.com AbbVie has announced that the first patient has been treated with its investigational…
Julia Sundari, Senior Director of Clinical Design and Analytics, IQVIA In 2023, clinical development productivity rose the highest it has…
Michael Cohen, Senior Director, Lead, Environmental Sustainability Robyn Owens, Manager, Recruitment and Engagement Both with the PPD clinical research business…
Brian S. McGowan, PhD, FACEHP, Chief Learning Officer and Co-Founder, ArcheMedX, Inc. In our journey through the lessons of cognitive,…
Ken Getz, MBA, Executive Director and Research Professor, Tufts Center for the Study of Drug Development, Tufts University School of…
Image Credit: © Murrstock – stock.adobe.com FDA and CluePoints have announced a new 3-year extension to their long-standing collaboration. The…
Image Credit: © Sebastian Kaulitzki – stock.adobe.com Johnson & Johnson has announced new data from the Phase III MARIPOSA study…
Image Credit: © iDoPixBox – stock.adobe.com Johnson & Johnson has announced first data from the Phase III PALOMA-3 study for…
ACT: Looking forward, what does the future of bring-your-own-device (BYOD) adoption look like? Liu: I think it’s already common. I…
ACT: What are the differences between consumer- and medical- grade wearables and their uses in clinical settings? Liu: The medical grade…
Image Credit: © Kaikoro – stock.adobe.com Conversations around the impact of artificial intelligence (AI) in the pharmaceutical industry seem to…
Meet your enrollment goals faster by recruiting from Evidation’s engaged, highly characterized health community.
Image credit: Axel Kock | stock.adobe.com Results from the TROPION-Lung01 Phase III trial (NCT04656652) show datopotamab deruxtecan (Dato-DXd) achieved superior…
Webinar Date/Time: Tuesday, June 25th, 2024 at 11am EDT|8am PDT|4pm BST|5pm CEST
Image credit: art4stock | stock.adobe.com The FDA has extended the Prescription Drug User Fee Act (PDUFA) target action date by…
Image credit: David A Litman | stock.adobe.com The FDA has approved Bristol Myers Squibb’s (BMS) Breyanzi (lisocabtagene maraleucel) to treat adults…
Image Credit: © Shuo – stock.adobe.com ConcertAI has announced its first-in-category predictive and generative artificial intelligence (AI) solutions. The new…
Image Credit: © Jakub Krechowicz – stock.adobe.com Inclusion of diverse populations continues to lag in clinical research. In this article,…
ACT: What are some challenges we are currently seeing with data security and accuracy in bring-your-own-device (BYOD) models? Liu: The…
Image credit: GraphicPapa | stock.adobe.com Since 2016, the FDA has released various guidance documents intended to promote diversity in clinical…
Image Credit: © photon_photo – stock.adobe.com Medidata has announced it has been selected by Lexicon Pharmaceuticals to help advance the…
Image Credit: © Murrstock – stock.adobe.com With ambitious goals to accelerate clinical trials, increase efficiency, and lower costs, many leading…
Image Credit: © PIC4U – stock.adobe.com Transcenta has announced results from the Phase I/IIa Cohort-G data for Osemitamab (TST001) plus…
Image credit: metamorworks | stock.adobe.com Data integrity is an ongoing concern across all R&D organizations, no matter what part of…
Image credit: Tierney | stock.adobe.com Abstract Background: ChatGPT usage remains limited to administrative and support work among drug developments professionals;…
Jeremy Wyatt, CEO of ActiGraph The technology that goes into wearable health monitoring devices has advanced by leaps and bounds…
Mike Hughes, Chief Product Officer, YPrime The field of drug development is placing a growing emphasis on the importance of…
Image Credit: © Murrstock – stock.adobe.com Beaconcure, a provider of artificial intelligence-enabled clinical data validation and automation, has announced a…
Image Credit: Adobe Stock Images/Hero Design Nimbus Therapeutics presented promising data from its Phase 1/2 clinical trial of NDI-101150, a…
Image Credit: © lidiia – stock.adobe.com Clario has announced a strategic partnership with medical equipment supplier for clinical trials, Emsere.…
Image Credit: © ipopba – stock.adobe.com From the promise of shrinking pancreatic tumors to a vaccine for Alzheimer’s, groundbreaking clinical…
Image Credit: Adobe Stock Images/Antonioguillem Sanofi announced positive results from a Phase II study for rilzabrutinib, a promising first-of-its-kind advanced…
Image Credit: © Aerial Mike – stock.adobe.com Boehringer Ingelheim and OSE Immunotherapeutics have announced a major expansion of their already-existing…
Image Credit: Adobe Stock Images/Oksana Smyshliaeva Edgewood Oncology announced that it has begun dosing patients as part of a Phase…
Image Credit: © Egor – stock.adobe.com While the number of randomized clinical trials (RCTs) for adult participants has increased over…
Image Credit: © Aerial Mike – stock.adobe.com In a presentation at the 2024 US Pharma and Biotech Summit, Michael Peel,…
Image Credit: Adobe Stock Images/Sebastian Kaulitzki GSK announced promising results from its Phase III clinical trials, SWIFT-1 and SWIFT-2, evaluating…
Image Credit: © iDoPixBox – stock.adobe.com A study recently published in JAMA Network Open compared response- and progression-based end points…
Image Credit: Adobe Stock Images/Robert Kneschke Eli Lilly announced promising results from the QWINT-2 and QWINT-4 Phase III trials for…
ACT: If companies choose not to adopt risk-based approaches, what are some of the largest risks they leave themselves susceptible…
David Alsadius, MD, PhD, Senior Medical Director, Oncology Center of Excellence, IQVIA Sergio Sánchez-Gambetta Director, Design Analytics, IQVIA Matt Simmons…
Image credit: 9dreamstudio | stock.adobe.com Roche’s dual GLP-1/GIP receptor agonist CT-388 produced positive findings treating obesity and type 2 diabetes…
Panna Sharma, CEO, Lantern Pharma ACT: While reaching the first-in-human stage is a significant achievement, what specific endpoints or biomarkers…
ACT: What do you think the RBQM space will look like in five years? Will we see any drastic changes…
Image credit: Ban | stock.adobe.com Four-year data from the long-term extension (LTE) of the POETYK PSO clinical trial program found…
Mike Hennessy Jr, president and CEO, MJH Life Sciences® Oncology clinical trials have always been a unique area in the…
Applied Clinical Trials May 2024 Issue (PDF) A Promising Future for Oncology R&D Where Innovation and Patients Meet to Improve…
Image credit: Dr_Microbe | stock.adobe.com Eisai and Biogen Inc. have initiated a rolling FDA submission for a subcutaneous (SC) version…
Brian S. McGowan, PhD, FACEHP, Chief Learning Officer and Co-Founder, ArcheMedX, Inc. This installment of my column is a little…
Discover effective strategies for outsourcing clinical trial operations to ensure trials run smoothly and within budget. Join us for a…
Hannah Jones, PhD, Senior Vice President, PBPK Consultancy Services, Certara Masoud Jamei, PhD, Senior Vice President, Research and Development, Certara More…
Image credit: Ocskay Mark | stock.adobe.com Merck is discontinuing the coformulation arm of the Phase III KeyVibe-010 trial (NCT05665595) analyzing…
Image Credit: © iDoPixBox – stock.adobe.com In an update on the Phase III CheckMate -73L trial, Bristol Myers Squibb announced…
Andreas Dreps, Senior VP and Global Head Drug Development Unit, ICON plc Over the years, extensive research and clinical trials…
Image credit: florence | stock.adobe.com In the Phase I/II CHORD trial (NCT05788536), a novel gene therapy was found to restore…
Image credit: MdBabul | stock.adobe.com Keytruda (pembrolizumab; Merck) plus chemotherapy as adjuvant therapy, with or without radiotherapy, in the treatment of…
ACT: Ken, could you give us an overview of the risk-based quality management (RBQM) study conducted by Tufts? Getz: Yes,…
Image credit: JHVEPhoto | stock.adobe.com The FDA has notified Moderna that it will be unable to finish reviewing its Biologics…
Image Credit: © NicoElNino – stock.adobe.com The Tufts Center for the Study of Drug Development (Tufts CSDD) is conducting an…
Image Credit: © putilov_denis – stock.adobe.com Patient enrollment has been a persistent challenge in clinical trials over the years across…
Image Credit: Adobe Stock Images/_veiksme_ The Pistoia Alliance, a prominent non-profit advocating for increased collaboration in life sciences R&D, announced…
Image credit: Jafree | stock.adobe.com Diarrheal diseases place a significant burden on public health in India, particularly among children and…
Image Credit: © ibreakstock | stock.adobe.com The FDA has granted Breakthrough Device Designation for Teal Health’s Teal Wand, a novel…
Image credit: koolsabuy | stock.adobe.com The first ever clinical trial conducted to evaluate an experimental treatment for diabetic macular ischemia…
Image Credit: © Murrstock – stock.adobe.com The FDA has cleared an Investigational New Drug Application (IND) for VYNE Therapeutics’ VYN202,…
Image credit: magicmine | stock.adobe.com Data from a Phase II trial for Johnson & Johnson’s novel targeted therapy TAR-200 showed…
Image Credit: © Tierney – stock.adobe.com In the design of a randomized clinical trial (RCT), estimations for expected event rate…
Are you interested in learning about clinical trial participant payment best practices? Join IQVIA Technologies to learn how an innovative…
ACT: How is artificial intelligence (AI) currently being used in clinical trials to ensure patient centricity? Nambisan: I think it’s…
ACT: How can feasibility studies be used to safeguard against trial complexities? Nambisan: So I touched on this just briefly…
ACT: What are some of the biggest mistakes stakeholders tend to make with their feasibility studies? How can those challenges…
Elizabeth Kelchner is the Associate Director of Data Management at Rho Sometimes relationships can continue even when things aren’t working out. However,…
Image credit: Juan Gärtner | stock.adobe.com The landscape of oncology drug development is rapidly evolving, particularly in the realm of…
Image credit: David A Litman | stock.adobe.com Calquence (acalabrutinib; AstraZeneca) plus standard-of-care chemoimmunotherapy produced a statistically significant and clinically meaningful improvement…
Image Credit: Adobe Stock Images/freshidea Walgreens and Boehringer Ingelheim have announced a joint venture, which will focus on the growth…
Image credit: Crystal light | stock.adobe.com Merck’s Keytruda (pembrolizumab) combined with trastuzumab, plus fluoropyrimidine- and platinum-containing chemotherapy, demonstrated promising improvements in…
Image Credit: © peshkova – stock.adobe.com An overwhelming amount of cancer patients express willingness to participate in clinical trials; however,…
Image credit: Jezper | stock.adobe.com Data from the Phase III STRIDE-10 trial show the promise of Merck’s novel 21-valent pneumococcal…
Image Credit: © Shuo – stock.adobe.com As artificial intelligence (AI) technology rapidly evolves, regulators around the world are tasked with…
Image Credit: © lidiia – stock.adobe.com Parexel and Palantir Technologies have announced a new multi-year strategic partnership to leverage artificial…
Image credit: NicoElNino | stock.adobe.com Artificial intelligence (AI) has become a cornerstone in the healthcare and pharmaceutical industry. The introduction…
ACT: How can differences across therapeutic areas be used to create more standardized electronic clinical outcome assessment (eCOA) solutions? Mooney:…
Image credit: Crystal light | stock.adobe.com The FDA has granted Priority Review to GSK’s supplemental Biologics License Application (sBLA) seeking…
ACT: Specifically in dermatology trials, which provide a lot of unique challenges, could you discuss some of the best practices…
ACT: Are there currently any regulatory challenges with the use of electronic clinical outcome assessments (eCOAs)? If so, how can…
Image credit: Matthieu | stock.adobe.com Compass Therapeutics, Inc’s novel bispecific antibody CTX-009 was granted Fast Track Designation (FTD) by the…
Monique Adams, PhD, Executive Director, Global Head of Diversity & Inclusion in Clinical Trials, Sanofi The lack of diversity in…
Image Credit: © Andrii Yalanskyi – stock.adobe.com A study recently published on JAMA Network Open examined a single center, double-blind,…
Image credit: InfiniteStudio | stock.adobe.com Findings from the Phase IIIb/IV LEVEL UP (NCT05601882) trial demonstrated the superiority of AbbVie’s Rinvoq (upadacitinib)…
Image Credit: © Proxima Studio – stock.adobe.com A study recently published in BMJ Open has identified differences in the characteristics…
Rust Felix, CEO and Co-founder of Slope While the potential of artificial intelligence (AI) has become more popular in the…
Image credit: MdBabul | stock.adobe.com Kura Oncology’s ziftomenib has been granted Breakthrough Therapy Designation (BTD) by the FDA for heavily…
Image credit: Pixel-Shot | stock.adobe.com Clinical trials are opportunities to advance how we diagnose, treat, and prevent disease, as well…
Image credit: neirfy | stock.adobe.com A new report from the Centers for Disease Control and Prevention (CDC) demonstrates the efficacy…
ACT: How does the utilization of clinical outcome assessments (COAs) differ across the various therapeutic areas? Mooney: That’s a great…
Image credit: Nathan Devery com | stock.adobe.com Results from the open-label ALITHIOS extension study demonstrated the long-term efficacy of first-line,…
Image Credit: © Blue Planet Studio – stock.adobe.com A recent survey study published on JAMA Network Open sought to evaluate…
Marcelo Alves Favaro, Associate Outcomes Researcher, MAPI Research Trust Caprice Sassano, Research Lead – Applied Sciences, HumanFirst, an ICON company…
Image credit: mi_viri | stock.adobe.com An analysis of eight randomized clinical trials (RCTs) found that the use of neoadjuvant platinum-based…
Dave Hanaman, President, Chief Commercial Officer, Co-Founder, Curavit Clinical Research. Japan’s digital health market is expected to show a compound…
Jill Sommerville, Senior Director Lauren Flood, Associate Director Matthew Ryan, Associate Director All with the digital and decentralized solutions for…
Vincent Keunen, Founder and CEO, Andaman7 New digital technologies are transforming possibilities in clinical research and driving a surge in…
Image Credit: © Sergey Nivens – stock.adobe.com Generating insights from data based on structured patients’ reports dates back to 1980.1-3…
Todd Rudo, MD, Chief Medical Officer, Clario Luc Dekie, PhD, Director of Scientific Affairs, Cardiology, Clario In an era prioritizing…
Bruce Hellman, Chief Patient Officer and Co-Founder, uMotif You’re setting forth on a long journey; you have your bags packed,…
Image Credit: © Shuo – stock.adobe.com A cross-sectional study recently published on JAMA Network Open analyzed the quality of responses…
Image Credit: © Egor – stock.adobe.com Reviva Pharmaceuticals has gained alignment from the FDA on its registrational Phase III program…
Image Credit: © peshkova – © peshkova – stock.adobe.com The University of Minnesota (UMN) Masonic Cancer Center is expected to…
Image credit: David A Litman | stock.adobe.com Data from the Phase III STARGLO trial (NCT04408638) show the combination of Columvi…
Image credit: Dr_Microbe | stock.adobe.com The combination of Krazati (adagrasib) plus cetuximab showed promise in patients with previously treated KRASG12C-mutated locally…
ACT: How much of a game-changer are artificial intelligence (AI) solutions to patients participating in clinical research? What are some…
April 5th 2024 Article Digital biomarkers, smartphones, and wearables are transforming clinical trials by revolutionizing remote data collection and providing…
ACT: How important is it that a level of human intervention remains with the oversight of these artificial intelligence (AI)…
Meeting the first patient in (FPI) deadline is a critical milestone for study teams who must first implement various systems…
Image credit: peterschreiber.media | stock.adobe.com Results from an interim analysis of an ongoing Phase III trial demonstrated the long-term safety…
Image credit: cendeced | stock.adobe.com An analysis of randomized, double-blind clinical trials found that psilocybin has a manageable adverse effect (AE)…
Image credit: Kaikoro | stock.adobe.com With the recent advances in generative AI (GenAI) with large language models (LLMs), GenAI-enabled or…
Flo Mowlem, PhD, VP of Science, ObvioHealth On March 25, ObvioHealth hosted a webinar on the execution of a medical…
ACT: Could you describe the importance of collaboration, specifically through data sharing, with regards to advancing the development of technology…
Image credit: jarun011 | stock.adobe.com Pfizer’s bivalent respiratory syncytial virus (RSV) prefusion F (RSVpreF) vaccine Abrysvo produced positive safety and…
